[1]
N. G. Rao, H. X. Jing, A. R. Kabir, and R. Surthi, “Omalizumab for the treatment of chronic spontaneous urticaria: a systematic review”, Int J Res Dermatol, vol. 7, no. 6, pp. 852–862, Oct. 2021.